Koios Medical

03/29/2025

Cancer diagnosis with ultrasound requires great vision. Koios software uses artificial intelligence and machine learning to provide clinical decision support (“DS”) for physicians and technologists.

We call it .

Email us at info@koiosmedical.com to learn more.

02/27/2025

🚨 Big news from ! 🚨

We’re excited to announce a strategic partnership with iCad to bring radiologists a comprehensive, multi-modality suite for breast cancer detection. By integrating Koios Medical's ™ with iCAD’s ProFound ® Breast Health Suite, we’re delivering an -powered pathway that enhances accuracy, efficiency, and workflow from screening to diagnosis.

🔹 Why it matters:
✅ Best-in-class across both breast & mammography.
✅ Streamlined implementation for radiology practices.
✅ Empowering clinicians with more precision & peace of mind.

“Our collaboration with iCAD is ultimately a customer-driven initiative. Radiologists are rapidly adopting best-of-breed AI solutions, and by offering an integrated ‘breast AI suite’, we’re taking a logical and necessary step forward.” – Chad McClennan, President & CEO of Koios Medical.

🔍 Find iCAD & Koios at : Booth AI-27, Hall X-1

[ ] Today iCAD and Koios Medical announced a strategic reseller partnership to deliver a comprehensive, multi-modality AI suite for breast cancer detection. This collaboration integrates iCAD’s ProFound AI® Breast Health Suite for mammography with Koios SmartUltrasound™, providing radiologists with an AI-powered pathway from screening to diagnosis.

“Our collaboration with iCAD is ultimately a customer-driven initiative. Breast imaging radiologists have long embraced innovation and are rapidly adopting best-of-breed AI solutions. Physicians seek accuracy, efficiency, and peace of mind. By offering an integrated ‘breast AI suite’ that includes both iCAD’s ProFound AI and Koios’ SmartUltrasound, we’re enabling a more comprehensive, AI-enhanced patient pathway. Streamlining AI acquisition and implementation across both mammography and breast ultrasound is a logical and necessary step forward,” said Chad McClennan, President & CEO of Koios Medical, Inc.

Dana Brown, President and CEO of iCAD, added, “This partnership reinforces iCAD’s commitment to delivering innovative AI solutions that empower radiologists and improve patient outcomes. By integrating iCAD’s ProFound AI Breast Health Suite with Koios’ SmartUltrasound, we are providing clinicians with a more complete, end-to-end, AI-powered approach to breast cancer screening and detection that enhances workflow efficiency and diagnostic accuracy.”

Find iCAD at ECR booth AI-27, Hall X-1

Read more: https://bit.ly/4i08CTi

01/22/2025

🔐 Unlocking Koios: Who We Are, How We Work, and Why It Matters

Listen as Ajit Jairaj, VP of Research & Development at Koios, breaks down who we are, how our for breast and thyroid ultrasound works, and why we do what we do.

👀 Watch now to learn more!

01/06/2025

is -powered software designed to detect and diagnose cancer in seconds, bringing speed and accuracy to the forefront of patient care. With cutting-edge technology, we’re transforming the way healthcare providers deliver critical diagnoses.

As we step into 2025, we’re excited about the advancements that lie ahead. Together, let’s continue shaping a brighter future for healthcare.

11/07/2024

📣 Koios will be at ! 📣

Visit us at Booth 4915 to see how can help lighten your workload and detect more cancers. Let’s connect to explore how we can support you in delivering elevated patient care. Schedule your meeting in advance here:

🔗 https://koiosdemo.as.me/schedule/3b74c888

11/03/2024

🌟 Join us at RSNA 2024! 🌟

From Dec. 1–4, 2024, come see us in Chicago at McCormick Place! Our expert team will be ready to answer your questions, explore new opportunities, and provide live product demonstrations. Don’t miss this chance to see in action!

Visit us at booth 4915 or find us online at www.koiosmedical.com. To schedule a one-on-one meeting, head to our website today! See you there!

10/24/2024

Did you know that dense breast tissue can increase the chance of breast cancer going undetected by mammograms Ultrasounds are recommended for these cases, and in combination with our software, cancer can be detected faster, earlier, with more accuracy.

10/18/2024

Around 13% of U.S. women will develop invasive breast cancer at some point in their lives, and one of the most important factors in combating it is early detection. That’s why Koios developed with assistance, so physicians can detect breast cancer faster, earlier, and with more accuracy.

10/15/2024

While some individuals with known risk factors may never develop cancer, staying informed about genetic, environmental, and lifestyle risks remains essential. However, the most effective way to detect early is through annual screenings starting at age 40. Koios Breast empowers physicians so they can better and more quickly detect and diagnose cancer.

10/10/2024

Early detection is critical in the fight against breast cancer, which is why it’s not only important for women over 40 to get screened, but to get the right type of screening. Ultrasound can more-easily detect breast cancer in dense breasts - which affects 40% of women over 40. software detects cancer faster, earlier, and with more accuracy than ultrasound alone.

04/11/2024

We’ve missed seeing smiling faces on the exhibit floor. Tomorrow at , swing by booth 501 for a warm welcome and see in action with in-person demos. Can’t wait to reconnect!